bioAffinity Technologies
BIAF
BIAF
6 hedge funds and large institutions have $192K invested in bioAffinity Technologies in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
6
Holders Change
+6
Holders Change %
–
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Creative Planning
Overland Park,
Kansas
|
$86K |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$60K |
| 3 |
3
Jane Street
New York
|
$32K |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$14K |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Creative Planning
Overland Park,
Kansas
| $86K | 29,545 | +29,545 | New |
|
|
2
Citadel Advisors
Miami,
Florida
| $60K | 20,583 | +20,583 | New |
|
|
3
Jane Street
New York
| $32K | 11,004 | +11,004 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $14K | 4,923 | +4,923 | New |
|
|
CFGS
5
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
6
Royal Bank of Canada
Toronto,
Ontario, Canada
| $0 | 1 | +1 | New |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $0 | 25 | +25 | New |
|